The Alpha-LIPOC ACID Story

Isolated by biochemists in 1951, alpha-Lipoic Acid plays a fundamental role in nearly all types of living cells
and may be considered essential for life itself. In humans and other mammals, alpha-Lipoic Acid serves as a
component of several key enzyme complexes, including pyruvate dehydrogenase and alpha-ketoglutarate
dehydrogenase. These enzymes are required in the Krebs cycle, which breaks down carbohydrate
molecules and converts them to energy.
Alpha-Lipoic Acid, sometimes referred to as Thioctic Acid, is found in many foods and is found in spinach,
red meat, potato, broccoli, liver, and tomato. It is also synthesized within the body.

An extraordinary antioxidant
Helps maintain normal blood sugar balance in the body
A proven cell protector
Produced with exceptional quality

Alpha-Lipoic Acid was long considered a growth factor for plants. Beginning in the 1950s, it was used
medicinally in Europe to maintain the integrity of liver and nerve cells. It wasnt until the late 1980s that
alpha-Lipoic Acid was recognized as an antioxidant with several unique properties. This discovery
accelerated research, human trials, and scientific publications on alpha-Lipoic Acid and heralded its rapidly
growing acceptance among consumers and the medical community.
Alpha-Lipoic Acid has been described in scientific publications as the ideal, universal and metabolic
antioxidant. Without question, it is one of the most remarkable of all dietary antioxidants. Yet it does much
more.
PROTECTS CELLS INSIDE AND OUT
Many antioxidants function in only one type of environment, such as vitamin E in fatty tissues and vitamin C
in watery medium of cells. In contrast, alpha-Lipoic Acid is distinguished by its ability to function in both the
water and the fatty regions of cells. Combined with its other properties, this characteristic enables alphaLipoic Acid to function as one of the most diverse antioxidants.
Antioxidants quench hazardous molecules known as free radicals, which damage cells and contribute to the
effects of aging. A powerful antioxidant in its own right, alpha-Lipoic Acid is routinely converted in the body to
Dihydrolipoic Acid, another highly efficient antioxidant. Together, these two forms of alpha-Lipoic Acid
neutralize a broad variety of free radicals.
To maintain health, the human body depends on a variety of cell-protecting antioxidants. However, the
myriad roles of alpha-Lipoic Acid distinguish it from most other antioxidants.
After antioxidants quench free radicals, they are, in a manner of speaking, used up. Again, alpha-Lipoic
Acid comes to the fore. Alpha-Lipoic Acid plays a central role in what researchers call the antioxidant
network. Alpha-Lipoic Acid helps recycle and replenish vitamins E and C, Gluthatione, and Coenzyme Q10,
all-important antioxidants, enabling the body to extend their biological lifespans. Because of its distinctive
chemical structure, alpha-Lipoic Acid also helps the body produce more of the powerful antioxidant
Glutathione.
In addition, research has also shown that antioxidants are synergistic and, as a team, have greater freeradical quenching properties than individual antioxidants. These exceptional qualities make alpha-Lipoic Acid
the universal antioxidant.
Protector of Cell Integrity

Through a variety of actions, including its antioxidant properties, alpha-Lipoic Acid can help maintain cell
integrity in the face of biological threats. Studies and clinical experiences have shown that alpha-Lipoic Acid
can help preserve normal liver function when the body is exposed to certain toxins.
Still other research has found that alpha-Lipoic Acid helps protect nerve function by normalizing the
transmission of nerve signals in the body. It also inhibits the activation of NFkB, a genetic transcription
factor that promotes cell destruction.
Increases Dietary Antioxidant Levels

Many scientists believe that most people do not consume sufficient amounts of dietary antioxidants,
particularly when they live and work under excessive free-radical exposure. Some people also inadvertently
limit their intake of alpha-Lipoic Acid when they seek to reduce their intake of red meat, a rich dietary source
of this nutrient. Regular, daily alpha-Lipolic Acid supplementation, can be used in :

stand-alone dietary supplements

multivitamin dietary supplements
dietary supplements that help maintain normal blood sugar balance
antioxidant dietary supplements
nonstimulant energy dietary supplements

an help maintain dietary antioxidant levels.

References
Barbiroli, B., Medori, R., Tritschler, H.J., Iotti, S., Lodi, R., and Zaniol, P. Thioctic acid stimulates muscle ATP
production in patients with Type II diabetes and diabetic polyneuropathy. Diabetes Und Stoffwechsel.
1996;3, 71-76.
Berkson, B.M. A conservative triple antioxidant approach to the treatment of hepatitis C. Medizinische Klinik.
1999;94 (Suppl 3), 84-89.
Biewenga, G.P., Haenen, G.R.M.M., and Bast, A. The pharmacology of the antioxidant lipoic acid. Cen
Pharmac. 1997;29(3), 315-331.
Biewenga, G.P., Haenen, G.R.M.M., and Bast, A. The role of lipoic acid in the treatment of diabetic
polyneuropathy. Drug Metabolism Reviews. 1997;29(4), 1025-1054.
Biewenga, G.P., Haenen, G., and Bast, A. An overview of lipoate chemistry, in eds., Fuchs, J. Packer, L.
Zimmer, G. Lipoic Acid in Health and Disease, NewYork: Marcel Dekker, 1997, p. 1-32.
Bustamante, J., Lodge, J.K., Marcocci, L., Tritschler, H.J., Packer, L., and Rihn, B.H. -Lipoic acid in liver
metabolism and disease. Free Radical Biology & Medicine. 1998;24(6), 1023-1039.
Gtz, M.E., Dirr, A., Burger, R., Janetzky, B., WeinmUller M., Chan, W.W., Chen, S.C., Reichmann, H.,
Rausch, W.D., and Riederer, P. Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1methyl-4-phenyl-1,2,3,6-tetreahydropyridine and diethyldithiocarbamate. European Journal of
Pharmacology-Molecular Pharmacology Section. 1994;226, 291-300.
Jacob, S., Henriksen, E.J., Ruus, P., Rett, K., Hermann, R., Wicklmayr, M., Nehrdich, D., Augustin, H.J., and
Dietze, G.J. The radical scavenger a-lipoic acid enhances insulin sensitivity in patients with NIDDM: a
placebo-controlled trial. Presented at Oxidants and Antioxidants in Biology, Santa Barbara, Calif., Feb 26March 1, 1997.

Jacob, S., Henriksen, E.J., Schiemann, A.L., Simon, I., Clancy, D.E., Tritschler, H.J., Jung, W.I., Augustin,
H.J., and Dietzee, G.J. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic
acid. Arzneimittel-Forschung Drug Research. 1995;45, 872-874.
Jacob, S., Henriksen, E.J., Tritschler, H.J., Augustin, H.J., and Dietze, G.J. Improvement of insulinstimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp
Clin Endocrinol Diabetes. 1996;104, 284-288.
Knudsen, C.A., Tappel, A.L., and North, J.A. Multiple antioxidants protect against heme protein and lipid
oxidation in kidney tissue. Free Radical Biology & Medicine. 1996;20, 165-173.
Konrad, T., Vicini, P., Kusterer, K., Hoflich, A., Assadkhani, A., Bohles, H.J., Sewell, A., Tritschler, H.J.,
Cobelli, C., and Usadel, K.H. -Lipoic Acid treatment decreases serum lactate and pyruvate concentrations
and improves glucose effectiveness in lean and obese patients with type 2 Diabetes. Diabetes Care.
1999;22(2), 280-287.
Lodge, J.K., and Packer, L. -Lipoic acid: The metabolic antioxidant. Nutrition and Immunology. 2000; 97-106.
Low, P.A., Nickander, K.K., and Tritschler, H.J. The roles of oxidative stress and antioxidant treatment in
experimental diabetic neuropathy. Diabetes. 1997;46 (Suppl. 2), 38-42.
Nagamatsu, M. Nickander, K.K., Schmelzer, J.D., Raya, A., Wittrock, D.A., Tritschler, H., and Low, P.A.
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in
experimental diabetic neuropathy. Diabetes Care. 1995;18, 1160-67.
Packer, L., Witt, E.H., and Tritschler, H.J. Alpha-lipoic acid as a biological antioxidant. Free Radical Biology
& Medicine. 1995;19(2), 227-250.
Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Mller, W., Tritschler, H.J., Mehnert, H., and
The Aladin II Study Group. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid ( -lipoic
acid): A two year multicenter randomized double-blind placebo-controlled trial (Aladin II). Free Radical
Research. 1999;31, 171-179.
Ruhnaut, K.J., Meissnert, H.P., Finn, J.R., Reljanovic, M., Lobisch, M., Schuette, K., Nehrdich, D., Tritschler,
H.J., Mehnert, H., and Ziegler, D. Effects of 3-week oral treatment with the antioxidant thioctic acid ( -lipoic
acid) in symptomatic diabetic polyneuropathy. Diabetic Medicine. 1999;16, 1040-1043.
Rett, K., Wicklmayr, M., Ruus, P., Nehrdich, D., Hermann, R., and Standl, E. Alpha-Liponsure (Thioctsure)
steigert die Insulinempfindlichkeit bergewichtiger Patienten mit Type- II-Diabetes. Diabetes Und
Stoffwechsel. 1996;5, 59-63.
Suzuki, Y.J., Aggarwal, B.B., and Packer, L. -Lipoic acid is a potent inhibitor of NF-kB activation in human T
cells. Biochemical and Biophysical Research Communications. 1992, 189(3), 1709-1715.
Ziegler, D., Hanefeld, M., Ruhnau, K.J., Hasche, H., Lobisch, M., Schtte, K., Kerum, G., Malessa, R., and
The Aladin III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxidant -lipoic
acid. A 7-month multicenter randomized controlled trial (ALADIN Study). Diabetes Care, 1999;22(8), 12961301.
Ziegler, D., Reljanovic, M., Mehnert, H., and Gries, F.A. -Lipoic acid in the treatment of diabetic
polyneuropathy in Germany: current evidence from clinical trials. Experimental Clinical Endocrinol Diabetes.
1999;107, 421-430.
Ziegler, D., Hanfeld, M., Ruhnau, K.J., Meibner, H.P., Lobisch, M., Schtte, K., Gries, F.A., and The Aladin
Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant -lipoic acid. A 3week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38, 1425-1433.